Cargando…

Inflammasomes in Colitis and Colorectal Cancer: Mechanism of Action and Therapies

Colorectal cancer is a multifactorial disease and a leading cause of cancer-related deaths worldwide. Inflammation is a driver across multiple stages in the development of colorectal cancer. The inflammasome is a cytosolic multiprotein complex of the innate immune system central to the regulation of...

Descripción completa

Detalles Bibliográficos
Autores principales:	Pandey, Abhimanu, Shen, Cheng, Man, Si Ming
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	YJBM 2019
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6747943/ https://www.ncbi.nlm.nih.gov/pubmed/31543710

Ejemplares similares

Pathogen-selective killing by guanylate-binding proteins as a molecular mechanism leading to inflammasome signaling
por: Feng, Shouya, et al.
Publicado: (2022)

Contradictory Effects of NLRP3 Inflammasome Regulatory Mechanisms in Colitis
por: Wagatsuma, Kohei, et al.
Publicado: (2020)

Inflammasomes and Colorectal Cancer
por: Keshavarz Shahbaz, Sanaz, et al.
Publicado: (2021)

Inflammasomes: Mechanisms of Action and Involvement in Human Diseases
por: Bulté, Dimitri, et al.
Publicado: (2023)

Inflammasomes in the gastrointestinal tract: infection, cancer and gut microbiota homeostasis
por: Man, Si Ming
Publicado: (2018)

Molecular mechanisms in colitis-associated colorectal cancer
por: Zhou, Royce W., et al.
Publicado: (2023)

Colorectal Cancer in Ulcerative Colitis: Mechanisms, Surveillance and Chemoprevention
por: Li, Wenqian, et al.
Publicado: (2022)

Clostridium perfringens virulence factors are nonredundant activators of the NLRP3 inflammasome
por: Mathur, Anukriti, et al.
Publicado: (2023)

Does NLRP3 Inflammasome and Aryl Hydrocarbon Receptor Play an Interlinked Role in Bowel Inflammation and Colitis-Associated Colorectal Cancer?
por: Ngui, Ivan Qi Han, et al.
Publicado: (2020)

Colorectal Dysplasia and Cancer Surveillance in Ulcerative Colitis
por: Reznicek, Emily, et al.
Publicado: (2021)

Traditional Chinese medicine for colorectal cancer treatment: potential targets and mechanisms of action
por: Chen, Jin-Fang, et al.
Publicado: (2023)

Update and latest advances in mechanisms and management of colitis-associated colorectal cancer
por: Dan, Wan-Yue, et al.
Publicado: (2023)

Mechanism of inflammasomes in cancer and targeted therapies
por: Gu, Qingdan, et al.
Publicado: (2023)

Biomarkers for colitis-associated colorectal cancer
por: Chen, Ru, et al.
Publicado: (2016)

Bacillus cereus non-haemolytic enterotoxin activates the NLRP3 inflammasome
por: Fox, Daniel, et al.
Publicado: (2020)

Inflammation-Driven Colorectal Cancer Associated with Colitis: From Pathogenesis to Changing Therapy
por: Nardone, Olga Maria, et al.
Publicado: (2023)

The cell biology of inflammasomes: Mechanisms of inflammasome activation and regulation
por: Sharma, Deepika, et al.
Publicado: (2016)

Plasma cells arise from differentiation of clonal lymphocytes and secrete IgM in Waldenström macroglobulinemia
por: Lim, Jun Hee, et al.
Publicado: (2022)

Potential Mechanisms of Probiotics Action in the Prevention and Treatment of Colorectal Cancer
por: Molska, Marta, et al.
Publicado: (2019)

Genomic characterization of colitis-associated colorectal cancer
por: Kameyama, Hitoshi, et al.
Publicado: (2018)

Bee Products and Colorectal Cancer—Active Components and Mechanism of Action
por: Moskwa, Justyna, et al.
Publicado: (2023)

Mechanisms of Action of Fruit and Vegetable Phytochemicals in Colorectal Cancer Prevention
por: Alzate-Yepes, Teresita, et al.
Publicado: (2023)

The role and mechanisms of action of microRNAs in cancer drug resistance
por: Si, Wengong, et al.
Publicado: (2019)

Therapeutic interventions target the NLRP3 inflammasome in ulcerative colitis: Comprehensive study
por: Ali, Fares E.M, et al.
Publicado: (2023)

Immunity against Moraxella catarrhalis requires guanylate‐binding proteins and caspase‐11‐NLRP3 inflammasomes
por: Enosi Tuipulotu, Daniel, et al.
Publicado: (2023)

Pretreatment with a Heat-Killed Probiotic Modulates the NLRP3 Inflammasome and Attenuates Colitis-Associated Colorectal Cancer in Mice
por: Chung, I-Che, et al.
Publicado: (2019)

Emerging actionable targets to treat therapy-resistant colorectal cancers
por: Grassilli, Emanuela, et al.
Publicado: (2022)

The role of autophagy in colitis-associated colorectal cancer
por: Wu, Yuhui, et al.
Publicado: (2018)

The Role of Dyslipidemia in Colitis-Associated Colorectal Cancer
por: Chen, Ke, et al.
Publicado: (2021)

Phytochemicals targeting glycolysis in colorectal cancer therapy: effects and mechanisms of action
por: Zhan, Lu, et al.
Publicado: (2023)

Biological therapy for ulcerative colitis
por: Arora, Zubin, et al.
Publicado: (2015)

Epigenetic Mechanisms of Inflammasome Regulation
por: Poli, Giulia, et al.
Publicado: (2020)

Cancer Immunotherapy: The Checkpoint between Chronic Colitis and Colorectal Cancer
por: Ephraim, Ramya, et al.
Publicado: (2022)

The Multifaceted Role and Regulation of Nlrp3 Inflammasome in Colitis-Associated Colo-Rectal Cancer: A Systematic Review
por: Zaharie, Roxana, et al.
Publicado: (2023)

Targeting inflammasome-dependent mechanisms as an emerging pharmacological approach for osteoarthritis therapy
por: Ramirez-Perez, Sergio, et al.
Publicado: (2022)

Circadian Clock Disruption Suppresses PDL1(+) Intraepithelial B Cells in Experimental Colitis and Colitis-Associated Colorectal Cancer
por: Liu, Jing-Lin, et al.
Publicado: (2021)

Baicalin Ameliorates DSS-Induced Colitis by Protecting Goblet Cells through Activating NLRP6 Inflammasomes
por: Li, Yanan, et al.
Publicado: (2022)

Early detection of ulcerative colitis-associated colorectal cancer
por: Zhen, Yu, et al.
Publicado: (2018)

The Role of microRNAs in Development of Colitis-Associated Colorectal Cancer
por: Bocchetti, Marco, et al.
Publicado: (2021)

Apigenin in cancer therapy: anti-cancer effects and mechanisms of action
por: Yan, Xiaohui, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_l96d4fmquh52i3i3qhbiig9m2d